Versant Venture Sells $7.4m in Monte Rosa Therapeutics Stock
Monte Rosa Therapeutics(GLUE.US) 10% Shareholder Sells US$7.4 Million in Common Stock
$Monte Rosa Therapeutics(GLUE.US)$ 10% Shareholder Versant Venture Capital VI, L.P. sold 1.13 million shares of common stock on Sep 20, 2024 at an average price of $6.5296 for a total value of $7.4
Monte Rosa Therapeutics(GLUE.US) 10% Shareholder Sells US$3.4 Million in Common Stock
$Monte Rosa Therapeutics(GLUE.US)$ 10% Shareholder Versant Venture Capital VI, L.P. sold 567.21K shares of common stock on Sep 11, 12, 13, 2024 at an average price of $6.0027 for a total value of $3.4
Monte Rosa Therapeutics Price Target Maintained With a $11.00/Share by Wedbush
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Companies Like Monte Rosa Therapeutics (NASDAQ:GLUE) Are In A Position To Invest In Growth